Artificial Organ Market 2024-2033: Technological Advancements, Competitive Landscape and Strategies

The artificial organ global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Artificial Organ Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size -
The artificial organ market size has grown strongly in recent years. It will grow from $22.23 billion in 2023 to $24.41 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%.  The  growth in the historic period can be attributed to increasing incidence of organ failure, rising aging population, improvements in materials and biocompatibility, research and development investments, increasing awareness.

The artificial organ market size is expected to see strong growth in the next few years. It will grow to $35.03 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%.  The growth in the forecast period can be attributed to growing demand for organ transplants, expansion of indications, personalized medicine trends, increasing investment in healthcare infrastructure, greater acceptance and social awareness. Major trends in the forecast period include regulatory landscape, increasing investment, personalized medicine, integration of ai and machine learning, global collaboration.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/artificial-organ-global-market-report


Scope Of Artificial Organ Market
The Business Research Company's reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Artificial Organ Market Overview

Market Drivers -
The rising geriatric population is expected to propel the growth of the artificial organ market going forward. The geriatric population refers to the population of people of 60 years and above requiring medical care. Artificial organs have the potential to significantly help the elderly in a variety of ways such as providing solutions to health problems such as organ failure that elderly people face to improve their quality of life. For instance, in October 2022, according to the World Health Organization, a US-based specialized health agency, Globally, 1 in 6 people will be 60 or older by 2030, and there will be a double number of individuals in this age group (2.1 billion) by 2050. Additionally, for instance, in June 2021, according to the UK Parliament's House of Commons Library, a UK-based information resource, by 2043, there will be a rise in the senior population in the UK, which will make up 24% of the total population (17.4 million people). Therefore, the rising geriatric population will drive the artificial organ market.

Market Trends -
Product innovations are a key trend in gaining popularity in the artificial organ market. Major companies operating in the artificial organ market are focused on developing innovative solutions to strengthen their position in the market. For instance, in December 2021, ALung Technologies, a US-based medical equipment manufacturer announced that its Hemolung respiratory support system, an artificial lung received approval from the Food and Drug Administration, a US-based regulatory organization. This artificial lung device is developed to treat COVID-19 patients avoiding ventilator use and further damage to their already stressed lungs and to control their respiratory and metabolic function. It is simple, safe, and effective and can be used for a range of applications such as cystic fibrosis and asthma.

The artificial organ market covered in this report is segmented –
1) By Organ Type: Artificial Heart, Artificial Kidney, Artificial Liver, Artificial Pancreas, Other Organ Types
2) By Material: Silicone, Plastic, Steel, Biomaterials
3) By Fixation: Implantable, External
4) By End Users: Hospitals, Ambulatory Surgical Centers, Laboratories And Diagnostic Centers, Research And Academic Institute, Other End Users

Get an inside scoop of the artificial organ market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=9430&type=smp


Regional Insights -
North America was the largest region in the artificial organ market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial organ market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Key Companies -
Major companies operating in the artificial organ market report are  Medtronic plc, Boston Scientific Services Private Limited., Abbott Laboratories Inc., Zimmer Biomet Holdings Inc., Ekso Bionics Holdings Inc., Cochlear Limited, Cyberonics Inc., LIVANOVA  plc, NeuroPace Inc., Ossur India Private Limited, Vivani Medical Inc., St Jude Medical India Private Limited, LifeNet Health Inc., Ottobock SE & Co. KGaA, Edwards Lifesciences India Pvt. Ltd., SynCardia Systems LLC, Demant A/S, Berlin Heart GmbH, Conmed Devices Private Limited, Wright Medical Group N.V., Baxter International Inc., B. Braun Melsungen AG, ABIOMED Inc., Carmat SA, Jarvik Heart Inc., Terumo Corporation, F. Hoffmann-La Roche Ltd., Tissium SAS, Organovo Holdings Inc., Satellite Bio, HeartWare plc, Arthrex Inc., Novartis AG, Stryker Corp. .

Table of Contents
1. Executive Summary
2. Artificial Organ Market Report Structure
3. Artificial Organ Market Trends And Strategies
4. Artificial Organ Market – Macro Economic Scenario
5. Artificial Organ Market Size And Growth
…..
27. Artificial Organ Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
 

Comments

Post a Comment

Popular posts from this blog

Global Antiepileptic Drugs Market Forecast Highlights Growth Outlook And Key Trends Over 2026–2030

Image
  The antiepileptic drugs market size has grown strongly in recent years. It will grow from $17.83 billion in 2025 to $18.74 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to epilepsy prevalence growth, first-generation drug reliance, hospital neurology expansion, seizure disorder awareness, generic drug penetration. The antiepileptic drugs market size is expected to see strong growth in the next few years. It will grow to $22.87 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to treatment-resistant epilepsy management, novel AED approvals, personalized neurology care, pediatric epilepsy diagnosis, long-acting formulations. Major trends in the forecast period include shift toward third-generation AEDs, growing use of combination therapy, expansion of pediatric epilepsy management, increased adoption of long-term seizure control, growth of gene...
Read more

Global Haptic Virtual Reality (VR) Fitness Suit Market Analysis Highlights Emerging Opportunities And Revenue Forecasts Through 2030

Image
  The haptic virtual reality (vr) fitness suit market size has grown exponentially in recent years. It will grow from $1.6 billion in 2025 to $2.05 billion in 2026 at a compound annual growth rate (CAGR) of 27.7%. The growth in the historic period can be attributed to rising popularity of virtual fitness applications, increasing consumer interest in immersive workouts, growth of wearable fitness technologies, expansion of home-based fitness solutions, improvements in haptic hardware capabilities. The haptic virtual reality (vr) fitness suit market size is expected to see exponential growth in the next few years. It will grow to $5.4 billion in 2030 at a compound annual growth rate (CAGR) of 27.4%. The growth in the forecast period can be attributed to increasing adoption of ai-driven fitness personalization, rising demand for remote and virtual training solutions, expansion of rehabilitation and therapeutic vr applications, growing integration of biometric feedback systems, advan...
Read more

2025 Strategic Guide to the Drugs For Benign Prostatic hypertrophy Market – Forecasts and Business Use Cases

Image
  The drugs for benign prostatic hypertrophy market size has grown strongly in recent years. It will grow from $4.28 billion in 2024 to $4.58 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to aging population, increased awareness, advancements in drug therapies, healthcare access. The drugs for benign prostatic hypertrophy market size is expected to see strong growth in the next few years. It will grow to $5.58 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to emerging markets, new drug developments, increasing awareness and education, regulatory approvals. Major trends in the forecast period include minimally invasive treatments, personalized medicine, combination therapies, patient-centered care, telemedicine and digital health, research and development. #Download Your Free Sample PDF:# https://www.thebusinessresearchcompany.com/sample.a...
Read more